Perlmutter Cancer Center Appoints Dr. Anne S. Renteria as Site Director for Transplantation and Cellular Therapy Center
Position
Director
Company
NYU Langone Health
New YorkBiotechnologyHealth CareMedicalTherapeuticsDescription
NYU Langone's Perlmutter Cancer Center at NYU Langone Hospital—Long Island has named Dr. Anne S. Renteria, MD, as site director for the Transplantation and Cellular Therapy Center, where she will lead the expansion of blood cancer programs and provide comprehensive care for patients.
Quick answer
Perlmutter Cancer Center Appoints Dr. Anne S. Renteria as Site Director for Transplantation and Cellular Therapy Center (December 20, 2024). NYU Langone Health is based in New York, New York, United States.
- Who is the new Director at NYU Langone Health?
- NYU Langone Health named Anne S. Renteria Director, announced December 20, 2024.
- What did NYU Langone Health announce on December 20, 2024?
- NYU Langone's Perlmutter Cancer Center at NYU Langone Hospital—Long Island has named Dr. Anne S. Renteria, MD, as site director for the Transplantation and Cellular Therapy Center, where she will lead the expansion of blood cancer programs and provide comprehensive care for patients.
- What does NYU Langone Health do?
- As a specialist in the field of cardio-oncology, Dr. Bloom focuses on early prevention, detection, treatment, and management of the potential cardiac effects of cancer treatments so that patients can safely continue...
- Where is NYU Langone Health based?
- NYU Langone Health is based in New York, New York, United States.
- Which similar companies made leadership changes around the same time?
- On Target Laboratories (December 10, 2024), Nanoscope Therapeutics (December 6, 2024), Incendia Therapeutics (December 3, 2024) and Pulse Biosciences, Inc. (January 10, 2025) also announced leadership changes within 45 days of NYU Langone Health.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- On Target Laboratories Appoints Bill Peters as President and Chief Executive Officer (December 10, 2024)
- Nanoscope Therapeutics Hires Ray Kaczmarek as Chief Technology and Manufacturing Officer (December 6, 2024)
- Incendia Therapeutics Appoints Bradford Smith as Chief Financial Officer (December 3, 2024)
- Pulse Biosciences Appoints Paul A. LaViolette as Chief Executive Officer (January 10, 2025)
- Actimed Therapeutics Appoints Dr. Fabio Dorigotti as Chief Medical Officer following Retirement of Frank Misselwitz (January 16, 2025)
- Faeth Therapeutics Appoints Dr. Stephen Hahn as Chief Medical Executive and Dr. Jayson Dallas as Chief Executive Officer (November 22, 2024)
Who to call at NYU Langone Health, and when
A new leader at NYU Langone Health brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day NYU Langone Health raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NYU Langone Health, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NYU Langone Health. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NYU Langone Health changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
NYU Langone Health changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.